HER2+ Breast Cancer: Applying Recent Data Updates at ASCO 2024 into Clinical Practice - Episode 10
Clinical Perspectives on Managing ILD Related to T-DXd
Breast cancer specialists discuss adverse events associated with T-DXd, focusing on monitoring for interstitial lung disease (ILD) and the role of re-challenging patients with T-DXd after resolution of grade 1 ILD.
Video content above is prompted by the following questions:
- What has your clinical experience been monitoring for T-DXd-related interstitial lung disease (ILD)?
- What do you think about the recent data presented about re-challenging patients with T-DXd after resolution of Grade 1 ILD?
Related Content:
